Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v3.5.0.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 01, 2016
Sep. 26, 2015
Cash flows from operating activities:    
Net income $ 20,186 $ 28,035
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 7,550 7,054
(Gain)Loss on disposal of assets 316 (1,086)
Provision (benefit) for deferred income taxes 998 100
Allowance for doubtful accounts (21) (14)
Stock-based compensation expense 3,890 2,975
(Increase) decrease in:    
Accounts receivable (4,149) 641
Inventories 517 2,341
Income taxes receivable (386)  
Other current assets 310 (48)
Other assets (773) 435
Increase (decrease) in:    
Accounts payable 1,114 156
Accrued expenses and other liabilities 2,033 914
Income taxes payable   (443)
Other noncurrent liabilities (260) (20)
Net cash provided by operating activities 31,325 41,040
Cash flows from investing activities:    
Investment in licensed technology (850) (1,425)
Capital expenditures (4,507) (4,697)
Proceeds from dispositions of equipment 2 1,645
Purchases of short-term investments (24,699) (20,666)
Proceeds from sale of short-term investments 35,389 17,459
Net cash provided by (used in) investing activities 5,335 (7,684)
Cash flows from financing activities:    
Proceeds from stock issued 830 772
Dividends to shareholders (8,321) (9,596)
Change in restricted cash 5 21
Net cash used in financing activities (7,486) (8,803)
Effect of exchange rate changes on cash and cash equivalents (1,084) (4,781)
Net increase (decrease) in cash and cash equivalents 28,090 19,772
Cash and cash equivalents, beginning of period 81,932 56,843
Cash and cash equivalents, end of period 110,022 76,615
Cash paid:    
Income taxes 9,047 14,575
Supplemental disclosure of noncash transactions:    
Common stock issued for shared distribution through accrued expenses and other liabilities $ 1,679 $ 3,535